Agency Forms Undergoing Paperwork Reduction Act Review, 23425-23427 [2023-07995]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
and annually during their terms.
Individuals who are selected for
appointment will be required to provide
detailed information regarding their
financial interests and, for example, any
work they do for the federal government
through research grants or contracts.
Disclosure of this information is
required in order for CDC ethics officials
to determine whether there is a conflict
between the SGE’s public duties as a
member of CHAC and the SGE’s private
interests, including an appearance of a
loss of impartiality as defined by federal
laws and regulations, and to identify
any required remedial action needed to
address the potential conflict.
CDC and HRSA review potential
candidates for CHAC membership when
a vacancy arises and provide a slate of
nominees for consideration to the
Secretary of HHS for final selection.
CDC and HRSA each publish a Federal
Register notice and will be using a joint
process to nominate nominees on a
rolling basis; thus, applications received
by CDC will be shared with HRSA for
consideration. Therefore, potential
candidates need only apply in response
to one of the Federal Register notices.
HHS notifies selected candidates of
their appointment near the start of the
term in December 2024, or as soon as
the HHS selection process is completed.
Note that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the following
items:
D A letter of interest or personal
statement from the nominee stating
how the nominee’s expertise would
inform the work of CHAC
D A biographical sketch of the nominee
(500 words or fewer)
D Current curriculum vitae or resume,
including complete contact
information (telephone numbers,
mailing address, and email address)
D At least one letter of recommendation
from person(s) not employed by HHS.
Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be
submitted by a person not employed
by an HHS agency (i.e., CDC, National
Institutes of Health, Food and Drug
Administration, etc.).
Nominations may be submitted
directly by the individual seeking
nomination or by the person/
organization recommending the
candidate. CDC and HRSA will collect
and retain nominations received for up
to two years to create a pool of potential
CHAC nominees.
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–07997 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1294]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The Maternal
Mortality Review Information
Application (MMRIA)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on January
11, 2023 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
23425
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
The Maternal Mortality Review
Information Application (MMRIA)
(OMB Control No. 0920–1294, Exp. 04/
30/2023)—Revision—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) seeks a Revision to
continue to collect information through
the Maternal Mortality Review
Information Application (MMRIA) for
three additional years. MMRIA is a
standardized data collection system that
allows Maternal Mortality Review
Committees (MMRCs) across the
country to abstract relevant data
(clinical and non-clinical) from a variety
of sources, document committee
decisions, and analyze data in order to
better understand the contributing
factors and preventability of pregnancyrelated deaths and thus to develop
recommendations for prevention.
Pregnancy-related deaths are defined
as a death as a result of pregnancy or
delivery complications, a chain of
events initiated by pregnancy, or the
aggravation of an unrelated condition by
the physiologic effects of pregnancy.
Considerable racial disparities exist,
with persons who are non-Hispanic
Native Hawaiian or Other Pacific
Islander, non-Hispanic American
Indian/Alaska Native and non-Hispanic
E:\FR\FM\17APN1.SGM
17APN1
23426
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
Black persons more likely to die from
pregnancy-related complications than
persons of other race-ethnicity
classifications. Findings from analyses
of aggregated MMRC data indicate that
about four out of five pregnancy-related
deaths are preventable.
Maternal Mortality Review is a
process by which a multidisciplinary
committee at the jurisdiction level
identifies and reviews cases of death
that occur during or within one year of
end of pregnancy. Members of MMRCs
typically represent public health,
obstetrics and gynecology, maternalfetal medicine, nursing, midwifery,
forensic pathology, mental and
behavioral health, community-based
organizations, and other relevant
partners. Through a partnership among
the MMRC, state vital records office,
and epidemiologists, deaths among
females of reproductive age are
examined to determine if they occurred
during pregnancy or within one year of
the end of pregnancy (i.e., pregnancyassociated deaths). Through this
process, potential cases of pregnancyrelated deaths (i.e., death from any
cause related to or aggravated by
pregnancy or its management) are then
identified. Review committees access
multiple sources of clinical and nonclinical information to understand the
circumstances surrounding a death in
order to determine pregnancyrelatedness and develop
recommendations for action to prevent
similar deaths in the future.
MMRIA is a standardized data
collection system designed to support
MMRC processes. Data are abstracted
and entered into MMRIA from various
sources, including death records,
autopsy reports, birth and fetal death
records, prenatal care records,
emergency department visit records,
hospitalization records, records from
other medical office visits, medical
transport records, social and
environmental profiles, mental health
profiles, and informant interviews. Case
narratives for committee reviews are
developed from the abstracted data
entered into MMRIA to facilitate
committee review, and committee
decisions based on their review are also
be entered into MMRIA.
The data collected in MMRIA is used
to facilitate an understanding of the
drivers of maternal mortality and
complications of pregnancy and
associated disparities and implement
data driven recommendations.
The burden estimates presented here
are applicable to the 39 jurisdictions
with funding support (which support 40
reporting jurisdictions through the
cooperative agreements Preventing
Maternal Deaths: Supporting Maternal
Mortality Review Committees (CDC–
RFA–DP19–1908) and Preventing
Maternal Mortality: Supporting
Maternal Mortality Review Committees
CDC–RFA–DP22–2211) and 13
remaining eligible jurisdictions that may
apply to receive funding in FY23 (CDC–
RFA–DP–23–0066). These jurisdictions
are required to compile a defined set of
information about pregnancy-related
deaths into MMRIA. It is estimated that
information will be collected for a total
of 2,240 pregnancy-associated deaths on
average, annually, among the 53
jurisdictions with current or potential
funding support through CDC–RFA–
DP19–1908, CDC–RFA–DP22–2211, and
CDC–RFA–DP–23–0066. For 34
jurisdictions, it is estimated that on
average, 15 hours of data abstraction are
required for each death entered into
MMRIA. The other 19 jurisdictions are
able to participate in a process to reduce
burden by which CDC uploads vital
records information into MMRIA rather
than jurisdiction staff manually
abstracting vital records. For these 19
jurisdictions, the estimated average is 14
hours of abstraction for each death
entered into MMRIA. For all
jurisdictions with current or potential
funding support through CDC–RFA–
DP19–1908, CDC–RFA–DP22–2211, and
CDC–RFA–DP–23–0066, an additional
24 minutes on average is needed to
enter the committee decisions into
MMRIA.
There are four changes that result in
this request for revision, with the first
three having an impact on the estimated
burden for this revision. First, through
additional congressional appropriations,
an additional 15 jurisdictions are now
funding recipients from the time of
initial OMB PRA approval. An
additional 13 jurisdictions are eligible to
apply for FY 23 funding. Overall, this
represents an increase from 25 to 53
respondents. Second, CDC estimates a
higher number of pregnancy-associated
deaths due to utilizing data from the
Pregnancy Mortality Surveillance
System (PMSS) rather than CDC
WONDER for these estimates. PMSS
estimates of pregnancy-associated
deaths are more accurate due to more
comprehensive and complete
identification of these deaths through
multiple case identification methods.
Third, CDC has been working with the
National Association for Public Health
Statistics and Information Systems on
an initiative that enables CDC to transfer
vital records data associated with CDC
identified pregnancy-associated deaths
directly into a jurisdiction’s instance of
MMRIA, reducing manual data entry
burden for the 19 respondents
participating in the initiative. Fourth, to
address user identified needs and
increase data use for analysis by
jurisdictions, a total of 60 new optional
fields were added to MMRIA, three
fields removed, and two fields
combined into one. None of the added
fields are required fields; 50 would only
be relevant for specific causes of death
or only when a specific type of record
is available; the majority of new
optional fields are drop down fields
with minimal response burden.
The changes resulted in an overall
increase of 21,932 burden hours. CDC
requests OMB approval for an estimated
annual burden of 33,482 hours. There is
no cost for respondents other than their
time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
lotter on DSK11XQN23PROD with NOTICES1
Type of respondents
Form name
Jurisdictions with current or potential funding support through CDC–
RFA–DP19–1908, CDC–RFA–DP22–2211, and CDC–RFA–DP–
23–0066 who manually abstract all data into MMRIA.
Jurisdictions with current or potential funding support through CDC–
RFA–DP19–1908, CDC–RFA–DP22–2211, and CDC–RFA–DP–
23–0066 for which CDC is uploading vital records into MMRIA
and jurisdiction staff abstract remaining data manually into
MMRIA.
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
PO 00000
Frm 00037
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
MMRIA abstraction
form.
34
42
15
MMRIA abstraction
form.
19
42
14
Fmt 4703
Sfmt 4703
E:\FR\FM\17APN1.SGM
17APN1
23427
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Form name
All jurisdictions with current or potential funding support through
CDC–RFA–DP19–1908, CDC–RFA–DP22–2211, and CDC–RFA–
DP–23–0066.
MMRIA committee decision form.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–07995 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Council for the Elimination of
Tuberculosis (ACET). ACET consists of
10 experts including the Chair in fields
associated with public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, and
preventive health care delivery.
DATES: Nominations for membership on
ACET must be received no later than
August 31, 2023. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
emailed to nchhstppolicy@cdc.gov with
the subject line ‘‘ACET 2024
Nomination’’ or faxed to (404) 639–
8600.
FOR FURTHER INFORMATION CONTACT:
Marah Condit, MS, Committee
Management Lead, Office of Policy,
Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–6, Atlanta,
Georgia 30329–4027. Telephone: (404)
639–3423; Email: MCondit@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council for the Elimination of
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
Tuberculosis (ACET) provides advice
and recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary, Department of Health and
Human Services (HHS); the Assistant
Secretary for Health, HHS; and the
Director, Centers for Disease Control
and Prevention (CDC). ACET (a) makes
recommendations on policies, strategies,
objectives, and priorities; (b) addresses
development and application of new
technologies; (c) provides guidance and
review of CDC’s TB prevention research
portfolio and program priorities; and (d)
reviews the extent to which progress has
been made toward eliminating TB.
Nominations are sought for persons
who have expertise and qualifications
necessary to contribute to the
accomplishment of the objectives of
ACET. Nominees will be selected on the
basis of their expertise in public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, or
preventive health care delivery. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET
objectives.
HHS policy stipulates that committee
membership be balanced in terms of
points of view represented and the
committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. CDC reviews potential candidates
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
Number of
respondents
Number of
responses per
respondent
53
Average
burden per
response
(in hours)
42
24/60
for ACET membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2024, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
and email address).
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (i.e., CDC,
National Institutes of Health, Food and
Drug Administration, etc.).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–07992 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\17APN1.SGM
17APN1
]]>Agencies
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Pages 23425-23427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07995]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-1294]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``The Maternal Mortality Review Information
Application (MMRIA)'' to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
January 11, 2023 to obtain comments from the public and affected
agencies. CDC received one comment related to the previous notice. This
notice serves to allow an additional 30 days for public and affected
agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and (e) Assess information
collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
The Maternal Mortality Review Information Application (MMRIA) (OMB
Control No. 0920-1294, Exp. 04/30/2023)--Revision--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) seeks a
Revision to continue to collect information through the Maternal
Mortality Review Information Application (MMRIA) for three additional
years. MMRIA is a standardized data collection system that allows
Maternal Mortality Review Committees (MMRCs) across the country to
abstract relevant data (clinical and non-clinical) from a variety of
sources, document committee decisions, and analyze data in order to
better understand the contributing factors and preventability of
pregnancy-related deaths and thus to develop recommendations for
prevention.
Pregnancy-related deaths are defined as a death as a result of
pregnancy or delivery complications, a chain of events initiated by
pregnancy, or the aggravation of an unrelated condition by the
physiologic effects of pregnancy. Considerable racial disparities
exist, with persons who are non-Hispanic Native Hawaiian or Other
Pacific Islander, non-Hispanic American Indian/Alaska Native and non-
Hispanic
[[Page 23426]]
Black persons more likely to die from pregnancy-related complications
than persons of other race-ethnicity classifications. Findings from
analyses of aggregated MMRC data indicate that about four out of five
pregnancy-related deaths are preventable.
Maternal Mortality Review is a process by which a multidisciplinary
committee at the jurisdiction level identifies and reviews cases of
death that occur during or within one year of end of pregnancy. Members
of MMRCs typically represent public health, obstetrics and gynecology,
maternal-fetal medicine, nursing, midwifery, forensic pathology, mental
and behavioral health, community-based organizations, and other
relevant partners. Through a partnership among the MMRC, state vital
records office, and epidemiologists, deaths among females of
reproductive age are examined to determine if they occurred during
pregnancy or within one year of the end of pregnancy (i.e., pregnancy-
associated deaths). Through this process, potential cases of pregnancy-
related deaths (i.e., death from any cause related to or aggravated by
pregnancy or its management) are then identified. Review committees
access multiple sources of clinical and non-clinical information to
understand the circumstances surrounding a death in order to determine
pregnancy-relatedness and develop recommendations for action to prevent
similar deaths in the future.
MMRIA is a standardized data collection system designed to support
MMRC processes. Data are abstracted and entered into MMRIA from various
sources, including death records, autopsy reports, birth and fetal
death records, prenatal care records, emergency department visit
records, hospitalization records, records from other medical office
visits, medical transport records, social and environmental profiles,
mental health profiles, and informant interviews. Case narratives for
committee reviews are developed from the abstracted data entered into
MMRIA to facilitate committee review, and committee decisions based on
their review are also be entered into MMRIA.
The data collected in MMRIA is used to facilitate an understanding
of the drivers of maternal mortality and complications of pregnancy and
associated disparities and implement data driven recommendations.
The burden estimates presented here are applicable to the 39
jurisdictions with funding support (which support 40 reporting
jurisdictions through the cooperative agreements Preventing Maternal
Deaths: Supporting Maternal Mortality Review Committees (CDC-RFA-DP19-
1908) and Preventing Maternal Mortality: Supporting Maternal Mortality
Review Committees CDC-RFA-DP22-2211) and 13 remaining eligible
jurisdictions that may apply to receive funding in FY23 (CDC-RFA-DP-23-
0066). These jurisdictions are required to compile a defined set of
information about pregnancy-related deaths into MMRIA. It is estimated
that information will be collected for a total of 2,240 pregnancy-
associated deaths on average, annually, among the 53 jurisdictions with
current or potential funding support through CDC-RFA-DP19-1908, CDC-
RFA-DP22-2211, and CDC-RFA-DP-23-0066. For 34 jurisdictions, it is
estimated that on average, 15 hours of data abstraction are required
for each death entered into MMRIA. The other 19 jurisdictions are able
to participate in a process to reduce burden by which CDC uploads vital
records information into MMRIA rather than jurisdiction staff manually
abstracting vital records. For these 19 jurisdictions, the estimated
average is 14 hours of abstraction for each death entered into MMRIA.
For all jurisdictions with current or potential funding support through
CDC-RFA-DP19-1908, CDC-RFA-DP22-2211, and CDC-RFA-DP-23-0066, an
additional 24 minutes on average is needed to enter the committee
decisions into MMRIA.
There are four changes that result in this request for revision,
with the first three having an impact on the estimated burden for this
revision. First, through additional congressional appropriations, an
additional 15 jurisdictions are now funding recipients from the time of
initial OMB PRA approval. An additional 13 jurisdictions are eligible
to apply for FY 23 funding. Overall, this represents an increase from
25 to 53 respondents. Second, CDC estimates a higher number of
pregnancy-associated deaths due to utilizing data from the Pregnancy
Mortality Surveillance System (PMSS) rather than CDC WONDER for these
estimates. PMSS estimates of pregnancy-associated deaths are more
accurate due to more comprehensive and complete identification of these
deaths through multiple case identification methods. Third, CDC has
been working with the National Association for Public Health Statistics
and Information Systems on an initiative that enables CDC to transfer
vital records data associated with CDC identified pregnancy-associated
deaths directly into a jurisdiction's instance of MMRIA, reducing
manual data entry burden for the 19 respondents participating in the
initiative. Fourth, to address user identified needs and increase data
use for analysis by jurisdictions, a total of 60 new optional fields
were added to MMRIA, three fields removed, and two fields combined into
one. None of the added fields are required fields; 50 would only be
relevant for specific causes of death or only when a specific type of
record is available; the majority of new optional fields are drop down
fields with minimal response burden.
The changes resulted in an overall increase of 21,932 burden hours.
CDC requests OMB approval for an estimated annual burden of 33,482
hours. There is no cost for respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Jurisdictions with current or potential MMRIA abstraction form. 34 42 15
funding support through CDC-RFA-DP19-
1908, CDC-RFA-DP22-2211, and CDC-RFA-
DP-23-0066 who manually abstract all
data into MMRIA.
Jurisdictions with current or potential MMRIA abstraction form. 19 42 14
funding support through CDC-RFA-DP19-
1908, CDC-RFA-DP22-2211, and CDC-RFA-
DP-23-0066 for which CDC is uploading
vital records into MMRIA and
jurisdiction staff abstract remaining
data manually into MMRIA.
[[Page 23427]]
All jurisdictions with current or MMRIA committee 53 42 24/60
potential funding support through CDC- decision form.
RFA-DP19-1908, CDC-RFA-DP22-2211, and
CDC-RFA-DP-23-0066.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-07995 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P
